Okay, let's tackle this question about dopamine in cardiogenic shock. The question is asking what lower doses of dopamine will increase. First, I need to recall the pharmacodynamics of dopamine. Dopamine has different effects depending on the dose. At low doses, it's a selective dopamine receptor agonist, particularly D1 receptors. These receptors are found in the renal, mesenteric, and coronary vasculature. Activation of D1 receptors causes vasodilation in these areas. So, lower doses would increase renal blood flow and urine output.

Now, the options might be something like increasing heart rate, increasing blood pressure, increasing urine output, or increasing cardiac output. The correct answer here would be related to renal vasodilation. Let me think about the options again. If the choices are A to D, and the correct answer is C, maybe "Urine output" is the right one. The other options: higher doses of dopamine stimulate beta-1 receptors, increasing heart rate and contractility, and at very high doses, alpha-1 effects dominate, causing vasoconstriction. So lower doses wouldn't affect those. The clinical pearl is the dose-dependent effects: low for renal, moderate for cardiac, high for vasoconstriction. Need to make sure each wrong option is explained. For example, if an option says "blood pressure," that's more from higher doses. If an option says "heart rate," that's beta-1 activation at moderate doses. The key is that low doses specifically target D1 receptors for renal effects.

**Core Concept**
Dopamine's effects are dose-dependent, acting on different receptors at varying concentrations. Low-dose dopamine (1–2 µg/kg/min) selectively activates **D1 receptors** in renal, mesenteric, and coronary vasculature, causing **vasodilation** and increased perfusion.

**Why the Correct Answer is Right**
At low doses, dopamine preferentially stimulates D1 receptors, which are located in the **afferent glomerular arterioles** of the kidney. This causes **vasodilation**, reducing renal vascular resistance and increasing **glomerular filtration rate (GFR)**. Clinically, this leads to **increased urine output**, making it beneficial in cardiogenic shock to protect renal function.

**Why Each Wrong Option is Incorrect**
**Option A:** "Heart rate" — Incorrect. Low-dose dopamine does not activate **beta-1 adrenergic receptors**, which are responsible for increasing heart rate (a moderate-dose effect).
**Option B:** "Blood pressure" — Incorrect. Low-dose dopamine causes **selective renal vasodilation** without systemic vasoconstriction. Blood pressure changes are minimal at this dose.
**Option D:** "Systemic vascular resistance" — Incorrect. Low-dose dopamine does not significantly alter systemic vascular resistance; higher doses (>5 µg/kg/min) activate **alpha-1 receptors**, increasing resistance.

**Clinical Pearl**
Remember the **"dopamine ladder"**:
- **Low dose (1–2 µg/kg/min):** D1 agonist → **Renal vasodilation**.
- **Moderate dose (2–10 µg/kg/min):** Beta-1 agonist → **Cardiac stimulation**.
- **High dose (>10 µg/kg/min):** Alpha-1 agonist

✓ Correct Answer: B. Urine output